Medtronic’s CoreValve Gains New Indication For High Risk Patients

Medtronic’s CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery.

Click here to read the full post on Forbes.

 

Leave a Reply

%d bloggers like this: